Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27698508
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Hosp+Pharm
2016 ; 51
(8
): 665-686
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Elbasvir/Grazoprevir
#MMPMID27698508
Cada DJ
; Kim AP
; Baker DE
Hosp Pharm
2016[Sep]; 51
(8
): 665-686
PMID27698508
show ga
Each month, subscribers to The Formulary Monograph Service receive 5 to 6
well-documented monographs on drugs that are newly released or are in late phase
3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees.
Subscribers also receive monthly 1-page summary monographs on agents that are
useful for agendas and pharmacy/nursing in-services. A comprehensive target drug
utilization evaluation/medication use evaluation (DUE/MUE) is also provided each
month. With a subscription, the monographs are available online to subscribers.
Monographs can be customized to meet the needs of a facility. Through the
cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in
this column. For more information about The Formulary Monograph Service, contact
Wolters Kluwer customer service at 866-397-3433. The September 2016 monograph
topics are barictinib, buprenorphine implants, sarilumab, sofosbuvir/velpatasvir,
and cholera vaccine, live, oral. The Safey MUE is on sofosbuvir/velpatasvir.